Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 325,958 shares at $13.69 ($4.5M) on 2018-02-14, disclosed to the SEC on 2018-02-16.
Open-market sale of $4.5M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.69 | 162,979 | $2.2M | 50.0% |
| 2 | $13.69 | 162,979 | $2.2M | 50.0% |
| Total | $13.69 avg | 325,958 | $4.5M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |